Conformational pathway of the polypeptide chain of chymotrypsin inhibitor-2 growing from its N terminus in vitro. Parallels with the protein folding pathway.

We have obtained a series of fragments growing from the N terminus of the protein chymotrypsin inhibitor-2 (C12) in order to study the development of structure on elongation of the polypeptide in solution. We present an extensive biophysical characterization of ten fragments using different conformational probes. Small fragments up to residue 40 of the 64-residue protein are disordered. Fragment (1-40) has non-native local hydrophobic clusters, but nevertheless does not bind 8-anilinonaphthalene-1-sulphonate (ANS). Hydrophobic regions in longer fragments become gradually more capable of binding ANS as the chain grows to completion, with a tendency to form native structures. Major changes in secondary structure and accessibility to hydrophobic sites occur in parallel, between (1-40) and (1-53), together with changes in hydrodynamic volume and flexibility. NMR studies of (1-53), the first fragment displaying tertiary interactions, show that a subcore is fully formed and the alpha-helix (residues 12 to 24) is of fluctuating structure. Fragments (1-53) and (1-60) share many properties with molten globule-like structures, with varying degrees or order. Fluorescence properties of the native fold are gradually recovered from fragments (1-60) to full-length C12, together with a decrease in hydrophobic exposure. A small degree of co-operativity of formation of structure appears when residue 60 is added, gradually increasing as residue 62 is added, but a full two-state co-operative transition appears only on addition of Arg62 and Val63. We believe this is the result of correct side-chain packing of the hydrophobic core, capping the major elements of secondary structure in C12 at this late stage, which is probed by the complete recovery of the fluorescence of the unique Trp5. The structures that develop as the polypeptide chain increases in length parallel the structural features present in the nucleus for the folding of intact protein, which develops in the transition state. The folding nucleus consists of much of the helix and the interactions made by Ala16 in the helix with residues in the core, especially with Leu49 and Ile57, with the rest of the structure being formed only very weakly in the transition state.

[1]  A. Fersht,et al.  Folding of chymotrypsin inhibitor 2. 2. Influence of proline isomerization on the folding kinetics and thermodynamic characterization of the transition state of folding. , 1991, Biochemistry.

[2]  A. Fersht,et al.  Single versus parallel pathways of protein folding and fractional formation of structure in the transition state. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Stryer,et al.  The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. , 1965, Journal of molecular biology.

[4]  J. Hejgaard,et al.  Amino acid sequence homology between a serine protease inhibitor from barley and potato inhibitor I , 1980 .

[5]  K. Kuwajima,et al.  The molten globule state as a clue for understanding the folding and cooperativity of globular‐protein structure , 1989, Proteins.

[6]  M. James,et al.  Crystal and molecular structure of the serine proteinase inhibitor CI-2 from barley seeds. , 1988, Biochemistry.

[7]  Christopher M. Dobson,et al.  Structural characterization of a highly–ordered ‘molten globule’ at low pH , 1994, Nature Structural Biology.

[8]  M. Kronman,et al.  Binding of naphthalene dyes to the N and A conformers of bovine α-lactalbumin , 1982 .

[9]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[10]  D. Engelman,et al.  Truncated staphylococcal nuclease is compact but disordered. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Fersht,et al.  Direct observation of better hydration at the N terminus of an alpha-helix with glycine rather than alanine as the N-cap residue. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Fersht,et al.  Folding of a nascent polypeptide chain in vitro: cooperative formation of structure in a protein module. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Fersht,et al.  Effect of cavity-creating mutations in the hydrophobic core of chymotrypsin inhibitor 2. , 1993, Biochemistry.

[14]  F M Poulsen,et al.  Refinement of the three-dimensional solution structure of barley serine proteinase inhibitor 2 and comparison with the structures in crystals. , 1991, Journal of molecular biology.

[15]  A. Fersht,et al.  Structure of the transition state for the folding/unfolding of the barley chymotrypsin inhibitor 2 and its implications for mechanisms of protein folding. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Shortle,et al.  NMR analysis of the residual structure in the denatured state of an unusual mutant of staphylococcal nuclease. , 1993, Structure.

[17]  Secondary structure of barley serine proteinase inhibitor 2 determined by proton nuclear magnetic resonance spectroscopy , 1987 .

[18]  A. Fersht,et al.  Structural factors contributing to the hydrophobic effect: the partly exposed hydrophobic minicore in chymotrypsin inhibitor 2. , 1995, Biochemistry.

[19]  P. S. Kim,et al.  Intermediates in the folding reactions of small proteins. , 1990, Annual review of biochemistry.

[20]  J. Ellis.  Proteins as molecular chaperones , 1987, Nature.

[21]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[22]  J. Sambrook,et al.  Protein folding in the cell , 1992, Nature.

[23]  A. Fersht,et al.  The structure of the transition state for folding of chymotrypsin inhibitor 2 analysed by protein engineering methods: evidence for a nucleation-condensation mechanism for protein folding. , 1995, Journal of molecular biology.

[24]  Richard R. Ernst,et al.  Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy , 1983 .

[25]  A. Fersht,et al.  Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition. , 1991, Biochemistry.

[26]  M. Rance.  Improved techniques for homonuclear rotating-frame and isotropic mixing experiments , 1987 .

[27]  A. Fersht,et al.  Search for nucleation sites in smaller fragments of chymotrypsin inhibitor 2. , 1995, Journal of molecular biology.

[28]  A. Fersht,et al.  Generation of a family of protein fragments for structure-folding studies. 1. Folding complementation of two fragments of chymotrypsin inhibitor-2 formed by cleavage at its unique methionine residue. , 1994, Biochemistry.

[29]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[30]  A. Fersht,et al.  The structure of the transition state for the association of two fragments of the barley chymotrypsin inhibitor 2 to generate native-like protein: implications for mechanisms of protein folding. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Dobson.  Unfolded proteins, compact states and molten globules: Current Opinion in Structural Biology 1992, 2:6–12 , 1992 .

[32]  N. A. Rodionova,et al.  Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe , 1991, Biopolymers.